![]() | |
Clinical data | |
---|---|
Trade names | Adreview, Azedra |
Other names | meta-iodobenzylguanidine mIBG, MIBG |
License data |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C8H10IN3 |
Molar mass | 275.093 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Iobenguane, or MIBG, is an aralkylguanidine analog of the adrenergic neurotransmitter norepinephrine (noradrenaline), typically used as a radiopharmaceutical.[3] It acts as a blocking agent for adrenergic neurons. When radiolabeled, it can be used in nuclear medicinal diagnostic and therapy techniques as well as in neuroendocrine chemotherapy treatments.
It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as pheochromocytomas and neuroblastomas.[4] With iodine-131 it can also be used to treat tumor cells that take up and metabolize norepinephrine.